WM D2
Alternative Names: WM-D2Latest Information Update: 05 Jan 2022
Price :
$50 *
At a glance
- Originator Well Marker Bio
- Developer Wellmarker Bio
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Colorectal cancer; Prostate cancer
Most Recent Events
- 21 Dec 2021 Early research in Colorectal cancer in South Korea (unspecified route) before December 2021 (Well Marker Bio pipeline, December 2021)
- 21 Dec 2021 Early research in Prostate cancer in South Korea (unspecified route) before December 2021 (Well Marker Bio pipeline, December 2021)